Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database

Breakpoint cluster region‐Abelson murine leukemia (BCR‐ABL) inhibitors markedly improve the prognosis of chronic myeloid leukemia. However, high treatment adherence is necessary for successful treatment with BCR‐ABL inhibitors. Therefore, an adequate understanding of the adverse event profiles of BC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Okada, Naoto, Niimura, Takahiro, Zamami, Yoshito, Hamano, Hirofumi, Ishida, Shunsuke, Goda, Mitsuhiro, Takechi, Kenshi, Chuma, Masayuki, Imanishi, Masaki, Ishizawa, Keisuke
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://ncbi.nlm.nih.gov/pubmed/30561126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1920
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak